Neijt JP - Search Results

1

The role of cytoreduction in ovarian cancer.

Zanaboni F, Heintz AP, Trimbos JB, van Lindert AC, Aalders JG, Neijt JP. Zanaboni F, et al. Among authors: neijt jp. Eur J Gynaecol Oncol. 1988;9(2):149-52. Eur J Gynaecol Oncol. 1988. PMID: 3133212

2

Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Vermorken JB, van Lindert AC, Heintz AP, Aartsen E, van Lent M, et al. Neijt JP, et al. Eur J Cancer. 1991;27(11):1367-72. doi: 10.1016/0277-5379(91)90011-2. Eur J Cancer. 1991. PMID: 1835850 Clinical Trial.

3

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Heintz AP, van Lent M, Trimbos JB, Bouma J, Vermorken JB, et al. Neijt JP, et al. J Clin Oncol. 1987 Aug;5(8):1157-68. doi: 10.1200/JCO.1987.5.8.1157. J Clin Oncol. 1987. PMID: 3114434 Clinical Trial.

4

A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy.

van Bommel PF, van Lindert AC, Kock HC, Leers WH, Neijt JP. van Bommel PF, et al. Among authors: neijt jp. Eur J Obstet Gynecol Reprod Biol. 1987 Sep;26(1):69-84. doi: 10.1016/0028-2243(87)90010-4. Eur J Obstet Gynecol Reprod Biol. 1987. PMID: 3311843 Review.

5

Cytoreductive surgery with or without preceding chemotherapy in ovarian cancer.

Neijt JP, Aartsen EJ, Bouma J, Heintz AP, van Lent M, van Lindert AC. Neijt JP, et al. Prog Clin Biol Res. 1985;201:217-23. Prog Clin Biol Res. 1985. PMID: 4095113 No abstract available.

6

Aspects of surgery in ovarian and endometrial carcinoma.

Aalders JG, Neijt JP. Aalders JG, et al. Among authors: neijt jp. Eur J Cancer. 1993;29A(4):624-8. doi: 10.1016/s0959-8049(05)80166-2. Eur J Cancer. 1993. PMID: 8435220 Review.

7

Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.

Willemse PH, vd Burg ME, vd Gaast A, Neijt JP, ten Bokkel Huinink WW, Aalders JG, de Vries EG. Willemse PH, et al. Among authors: neijt jp. Cancer Chemother Pharmacol. 1990;26 Suppl:S51-4. doi: 10.1007/BF00685420. Cancer Chemother Pharmacol. 1990. PMID: 2112053

8

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Vriesendorp R, Kooyman CD, van Lindert AC, Hamerlynck JV, van Lent M, van Houwelingen JC, et al. Neijt JP, et al. Lancet. 1984 Sep 15;2(8403):594-600. doi: 10.1016/s0140-6736(84)90594-4. Lancet. 1984. PMID: 6147640 Clinical Trial.

9

Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.

Neijt JP, van Lindert AC, Vendrik CP, Roozendaal KJ, Struyvenberg A, Pinedo HM. Neijt JP, et al. Cancer Treat Rep. 1980 Feb-Mar;64(2-3):323-6. Cancer Treat Rep. 1980. PMID: 6773656

10

Continuous infusion of 5-fluorouracil in ovarian cancer patients refractory to cisplatin and carboplatin.

de Graeff A, van Hoef ME, Tjia P, Heintz AP, Neijt JP. de Graeff A, et al. Among authors: neijt jp. Ann Oncol. 1991 Oct;2(9):691-2. doi: 10.1093/oxfordjournals.annonc.a058052. Ann Oncol. 1991. PMID: 1742226 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters